Solas, C., Bregigeon, S., Faucher‐Zaegel, O., Quaranta, S., Obry‐Roguet, V., Tamalet, C., . . . Poizot‐Martin, I. (2017). Ledipasvir and tenofovir drug interaction in human immunodeficiency virus–hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety. Br J Clin Pharmacol.

Solas, Caroline, Sylvie Bregigeon, Olivia Faucher‐Zaegel, Sylvie Quaranta, Véronique Obry‐Roguet, Catherine Tamalet, Bruno Lacarelle, and Isabelle Poizot‐Martin. "Ledipasvir and Tenofovir Drug Interaction in Human Immunodeficiency Virus–hepatitis C Virus Coinfected Patients: Impact On Tenofovir Trough Concentrations and Renal Safety." Br J Clin Pharmacol 2017.

Solas, Caroline, et al. "Ledipasvir and Tenofovir Drug Interaction in Human Immunodeficiency Virus–hepatitis C Virus Coinfected Patients: Impact On Tenofovir Trough Concentrations and Renal Safety." Br J Clin Pharmacol 2017.